Skip to main content

Headlines

Cyclo Therapeutics Gets Notice Of Allowance For Patent Regarding Treatment Of Alzheimer's Disease
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Vera Therapeutics Reaches Analyst Target Price
posted:
by: Nasdaq ETFs
#channels:: #All, #Business, #Nasdaq, #NasdaqETFs, #ETFs, #Stocks
Could Sarepta Therapeutics Become the Next Vertex Pharmaceuticals?
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
1 Setback and 1 Opportunity for CRISPR Therapeutics Stock
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
Why Sarepta Therapeutics Stock Zoomed Nearly 5% Higher Today
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Better Growth Stock: Intellia Therapeutics vs. CRISPR Therapeutics
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
CRISPR Therapeutics AG (CRSP) Outpaces Stock Market Gains: What You Should Know
posted:
by: Nasdaq Stocks
#channels:: #All, #Business, #Stocks, #Nasdaq, #NasdaqStocks
Hoth Therapeutics Received FDA Clearance To Broaden HT-001 Clinical Trial
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Viridian Therapeutics Prices Public Offering Of About 7.14 Mln Shares At $21.00/shr
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Here's Why CRISPR Therapeutics Stock Rose 54% Last Year
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Why Vera Therapeutics Stock Soared by 22% This Week
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Chart of the Day: Autolus Therapeutics - Effective Cancer Treatments
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
Acorda Therapeutics To Regain Worldwide Commercialization Rights To FAMPYRA
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
The Zacks Analyst Blog Highlights DaVita, monday.com, GitLab, Light & Wonder and Sarepta Therapeutics
posted:
by: Nasdaq Technology
#channels:: #All, #Business, #Nasdaq, #Technology, #NasdaqTechnology, #Stocks
Sarepta Therapeutics (SRPT) Shares Cross Above 200 DMA
posted:
by: Nasdaq Stocks
#channels:: #All, #Business, #Stocks, #Nasdaq, #NasdaqStocks